The core components of CRISPR-based genome-editing therapies are bacterial proteins called nucleases that can stimulate ...

Genetic changes are a significant cause of infertility, impacting over 15% of the global population. TLE6, a major protein ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends ...

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock. This data can help you ...

Infertility is a major global challenge associated with physiological and psychological impact. Genetic mutations that affect early embryonic ...

Bank of America Securities analyst Alec Stranahan maintained a Sell rating on Editas Medicine (EDIT – Research Report) yesterday and set a ...

Researchers at the Experimental and Clinical Research Center (ECRC), a joint institution of the Max Delbrück Center and ...

the resulting protein could still have enough function to perform its critical roles." SPLICER builds upon the popular CRISPR-Cas9 gene editing platform -- with key changes. CRISPR-Cas9 systems ...

Gene editing involves precise changes in DNA sequences using enzymes, revolutionizing medical, agricultural, and research ...

Editas Medicine (EDIT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Yanan Zhu ...

Researchers have identified a molecular mechanism driving the structural abnormalities leading to lissencephaly that have ...

Kansas State University researchers have reported a breakthrough in developing wheat-based foods that contain lower amounts ...